BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10702606)

  • 1. Soybean isoflavones as an alternative to traditional hormone replacement therapy: are we there yet?
    Burke GL; Vitolins MZ; Bland D
    J Nutr; 2000 Mar; 130(3):664S-5S. PubMed ID: 10702606
    [No Abstract]   [Full Text] [Related]  

  • 2. Soy isoflavones for postmenopausal symptoms. An examination of evidence.
    Hulem R; Blair RM
    Adv Nurse Pract; 2006 May; 14(5):32-8; quiz 39. PubMed ID: 16972423
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypoglycemic effects of isoflavones unproven.
    Messina M
    J Womens Health (Larchmt); 2005; 14(6):468-9; author reply 470. PubMed ID: 16114998
    [No Abstract]   [Full Text] [Related]  

  • 4. Soy and cardiovascular disease: cholesterol lowering and beyond.
    Anthony MS
    J Nutr; 2000 Mar; 130(3):662S-3S. PubMed ID: 10702605
    [No Abstract]   [Full Text] [Related]  

  • 5. [A prospective controlled study on the clinical therapeutic effect of treatment of menstrual syndrome by isoflavone of soybean].
    Xue X; Niu J; Wang J; Ai H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Sep; 24(9):835-6. PubMed ID: 15495833
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone replacement therapy: estrogen after menopause.
    Gibaldi M
    Pharmacotherapy; 1996; 16(3):366-75. PubMed ID: 8726594
    [No Abstract]   [Full Text] [Related]  

  • 7. [Postmenopausal hormone replacement therapy and cardiovascular disease].
    Høibraaten E
    Tidsskr Nor Laegeforen; 2002 Jun; 122(16):1564-5. PubMed ID: 12119783
    [No Abstract]   [Full Text] [Related]  

  • 8. Postmenopausal hormone replacement therapy for the primary prevention of chronic conditions: recommendations and rationale.
    Berg AO;
    Am J Nurs; 2003 Jun; 103(6):83-91. PubMed ID: 12802162
    [No Abstract]   [Full Text] [Related]  

  • 9. [The role of phytoestrogen therapy in relieving postmenopausal symptoms].
    Szkutnik-Fiedler D; Jedrzejczyk M; Grześkowiak E; Bartkowiak-Wieczorek J; Seremak-Mrozikiewicz A; Drews K; Mrozikiewicz PM
    Ginekol Pol; 2010 Dec; 81(12):929-34. PubMed ID: 21395085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial, breast and liver safety of soy isoflavones plus Lactobacillus sporogenes in post-menopausal women.
    Colacurci N; De Franciscis P; Atlante M; Mancino P; Monti M; Volpini G; Benvenuti C
    Gynecol Endocrinol; 2013 Mar; 29(3):209-12. PubMed ID: 23194023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal hormone therapy: the heart of the matter.
    Guallar E; Manson JE; Laine C; Mulrow C
    Ann Intern Med; 2013 Jan; 158(1):69-70. PubMed ID: 23277904
    [No Abstract]   [Full Text] [Related]  

  • 12. The hypoglycemic effects of soy isoflavones on postmenopausal women.
    Cheng SY; Shaw NS; Tsai KS; Chen CY
    J Womens Health (Larchmt); 2004 Dec; 13(10):1080-6. PubMed ID: 15650341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial.
    Pines A; Sturdee D
    Ann Intern Med; 2010 Jul; 153(1):61; author reply 61-2. PubMed ID: 20621912
    [No Abstract]   [Full Text] [Related]  

  • 14. Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial.
    Sullivan JL
    Ann Intern Med; 2010 Jul; 153(1):61; author reply 61-2. PubMed ID: 20621911
    [No Abstract]   [Full Text] [Related]  

  • 15. Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial.
    Harman SM; Brinton EA; Naftolin F; Merriam GR; Cedars MI; Freeman RG; Santoro N
    Ann Intern Med; 2010 Jul; 153(1):60-1; author reply 61-2. PubMed ID: 20621909
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phytoestrogens--an alternative to hormonal replacement therapy].
    Drosdzol A; Skrzypulec V; Nowosielski K; Piela B; Rozmus-Warcholińska W; Walaszek A
    Wiad Lek; 2004; 57 Suppl 1():74-7. PubMed ID: 15884209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of soybean isoflavones on relieving menopausal syndrome and osteoporosis].
    Liu Z; Wang Y
    Wei Sheng Yan Jiu; 2007 Sep; 36(5):643-5. PubMed ID: 18095582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focus on cardiovascular health: hormone replacement therapy, estrogen replacement therapy, and selective estrogen receptor modulators.
    Walsh BW
    J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S6-8. PubMed ID: 12625632
    [No Abstract]   [Full Text] [Related]  

  • 19. Soy phytoestrogens: an adjunct to hormone replacement therapy?
    Birge SJ
    Menopause; 2000; 7(4):209-12. PubMed ID: 10914612
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormone therapy and cardiovascular disease in the early postmenopause: the WHI data revisited.
    Pines A; Sturdee DW; Birkhäuser MH;
    Climacteric; 2007 Jun; 10(3):195-6. PubMed ID: 17487646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.